| Date | Company Name | Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|---|
| Apr 26, 2022 | Valneva | Post-IPO Debt | — | Biotechnology | Yes |
| Feb 22, 2022 | Somatus | Series E | — | Health Care | — |
| Oct 13, 2021 | Lark | Series D | — | Artificial Intelligence | Yes |
| Jan 5, 2021 | Terns Pharmaceuticals | Series C | — | Biotechnology | Yes |
| Jun 23, 2020 | Somatus | Series C | — | Health Care | Yes |
| Dec 5, 2019 | Black Diamond Therapeutics | Series C | — | Biotechnology | — |
| Jan 9, 2019 | Black Diamond Therapeutics | Series B | — | Biotechnology | — |
| Jan 4, 2019 | Schrödinger | Series E | — | Biotechnology | — |
| Oct 26, 2017 | Phoenix | Series Unknown | — | Consumer Research | Yes |
| Jun 22, 2017 | Proteon Therapeutics | Post-IPO Equity | — | Biotechnology | Yes |
| Jun 14, 2017 | Aziyo Biologics | Series Unknown | — | Biotechnology | — |
| May 16, 2017 | Synlogic | Series C | — | Biotechnology | — |
| Jul 18, 2016 | Ardelyx | Post-IPO Equity | — | Biotechnology | — |
| Feb 17, 2016 | Synlogic | Series B | — | Biotechnology | — |
| Jun 19, 2014 | Horizon Pharma | Post-IPO Debt | — | Biopharma | Yes |
| May 16, 2014 | Proteon Therapeutics | Series D | — | Biotechnology | — |
| Apr 19, 2011 | Cytokinetics | Post-IPO Equity | — | Biopharma | Yes |